CCM
CRL icon

Community Capital Management’s Charles River Laboratories CRL Stock Holding History

Community Capital Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$1.45M Buy
7,400
+400
+6% +$82.1K 2.31% 17
2023
Q2 		$1.47M Buy
7,000
+500
+8% +$99.5K 2.04% 22
2023
Q1 		$1.31M Hold
6,500
– – 1.73% 26
2022
Q4 		$1.42M Buy
6,500
+1,550
+31% +$338K 1.84% 26
2022
Q3 		$974K Buy
+4,950
New +$1.07M 1.28% 33

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Community Capital Management's CRL Position: Q3 2023 in Review

Community Capital Management increased its Charles River Laboratories (CRL) stake by 5.7% in Q3 2023, buying an estimated $82.1K and bringing the position to 7,400 shares worth $1.45M. The position accounts for 2.31% of the portfolio, ranked #17.

Community Capital Management first reported a position in CRL in Q3 2022 and has held it in 5 quarters since. The position peaked at $1.47M in Q2 2023. 621 funds tracked by Wall St. Rank hold CRL as of Q3 2023.

  • Community Capital Management held 7,400 shares of Charles River Laboratories worth $1.45M as of Q3 2023.
  • Community Capital Management bought 400 Charles River Laboratories shares in Q3 2023, an estimated $82.1K.
  • Charles River Laboratories made up 2.31% of Community Capital Management's portfolio in Q3 2023, its #17 holding.
  • Community Capital Management first reported a position in Charles River Laboratories in Q3 2022 and has held it in 5 quarters since.
  • Community Capital Management's Charles River Laboratories position peaked at $1.47M in Q2 2023.
  • 621 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2023.

Based on Community Capital Management's 13F filing for Q3 2023, filed 24 Oct 2023.